5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.42▼ | 0.41▼ | 0.42▼ | 0.40▲ | 0.35▲ |
MA10 | 0.42▼ | 0.41▼ | 0.41▲ | 0.39▲ | 0.38▲ |
MA20 | 0.41▲ | 0.40▲ | 0.40▲ | 0.35▲ | 1.14▼ |
MA50 | 0.40▲ | 0.39▲ | 0.38▲ | 0.39▲ | 2.01▼ |
MA100 | 0.38▲ | 0.37▲ | 0.35▲ | 1.28▼ | 2.38▼ |
MA200 | 0.36▲ | 0.34▲ | 0.36▲ | 2.00▼ | 8.21▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.001▲ | 0.001▲ | 0.017▲ | -0.011▼ |
RSI | 53.056▲ | 57.592▲ | 59.369▲ | 54.277▲ | 30.934▼ |
STOCH | 47.481 | 74.024 | 77.630 | 89.771▲ | 25.679 |
WILL %R | -53.819 | -37.170 | -37.170 | -10.350▲ | -91.101▼ |
CCI | -51.899 | 31.380 | 54.462 | 127.217▲ | -35.122 |
Monday, April 28, 2025 05:00 PM
Read Our Latest Research Report on LPX Louisiana-Pacific Stock Up 0.8 % NYSE LPX opened at $87.20 on Tuesday. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.86 and a quick ...
|
Friday, April 25, 2025 10:00 AM
Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced it will present preclinical data of FL-501 in a poster ...
|
Friday, April 25, 2025 03:00 AM
CAMBRIDGE, Mass., April 25, 2025 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced it ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.408 | 0.43 | 0.408 | 0.4152 | 217,482 |
30/04/25 | 0.3956 | 0.43 | 0.38 | 0.4181 | 1,495,543 |
29/04/25 | 0.391 | 0.3964 | 0.3851 | 0.3882 | 241,416 |
28/04/25 | 0.39 | 0.40 | 0.386 | 0.3956 | 512,509 |
25/04/25 | 0.3931 | 0.40 | 0.38 | 0.3999 | 342,508 |
24/04/25 | 0.3953 | 0.40 | 0.3751 | 0.3931 | 482,296 |
23/04/25 | 0.372 | 0.40 | 0.372 | 0.395 | 421,943 |
22/04/25 | 0.354 | 0.3939 | 0.3421 | 0.386 | 264,621 |
21/04/25 | 0.36 | 0.3664 | 0.338 | 0.3596 | 255,913 |
17/04/25 | 0.358 | 0.3748 | 0.35 | 0.3634 | 305,646 |
|
|
||||
|
|
||||
|
|